Skip to content

Clinical trials

Phase 1 Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Phase: Phase 1 Clear all

302 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20055
20063
20073
20086
200910
20107
20114
20124
20131
20143
20151
20163
20171
20186
20199
20209
202112
202212
202312
202443
202561
202683

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174
Recruiting59
Not yet recruiting27
Active, not recruiting20
Terminated9
Unknown status9
Withdrawn2
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S44
Eli Lilly and Company30
Pfizer13
Amgen11
AstraZeneca7
Fujian Shengdi Pharmaceutical Co., Ltd.7
Shanghai Minwei Biotechnology Co., Ltd7
Zealand Pharma6
Beijing QL Biopharmaceutical Co.,Ltd5
Boehringer Ingelheim5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight302
Obesity267
Diabetes Mellitus, Type 232
Diabetes Mellitus13
Weight Loss9
Non-alcoholic Fatty Liver Disease8
Insulin Resistance7
Body Weight6
Diabetes Mellitus, Type 15
Fatty Liver4

Trials

Showing 26 to 50 of 302. Each trial links to its page on Pharma Observatory.

202 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.